GRADE Guidelines: 22. The GRADE approach for tests and strategies - from test accuracy to patient important outcomes and recommendations.

Schünemann, Holger J; Mustafa, Reem A; Brozek, Jan; Santesso, Nancy; Bossuyt, Patrick M; Steingart, Karen R; Leeflang, Mariska; Lange, Stefan; Trenti, Tommaso; Langendam, Miranda; Scholten, Rob; Hooft, Lotty; Murad, Mohammad Hassan; Jaeschke, Roman; Rutjes, Anne; Singh, Jasvinder; Helfand, Mark; Glasziou, Paul; Rodriguez, Ingrid Arévalo; Akl, Elie A; ... (2019). GRADE Guidelines: 22. The GRADE approach for tests and strategies - from test accuracy to patient important outcomes and recommendations. Journal of clinical epidemiology, 111, pp. 69-82. Elsevier 10.1016/j.jclinepi.2019.02.003

[img] Text
Schünemann JClinEidemiol 2019.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy
[img]
Preview
Text
Schünemann JClinEidemiol 2019.pdf - Accepted Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (1MB) | Preview

OBJECTIVES

This article describes GRADE's framework of moving from test accuracy to patient or population important outcomes. We focus on the common scenario when studies directly evaluating the effect of diagnostic and other tests or strategies on health outcomes are not available or are not providing the best available evidence.

STUDY DESIGN AND SETTING

Using practical examples, we explored how guideline developers and other decision makers can use information from test accuracy to develop a recommendation by linking evidence that addresses downstream consequences. Guideline panels should develop an analytic framework that summarizes the actions that follow from applying a test, and the consequences.

RESULTS

We describe GRADE's current thinking about the overall certainty of the evidence (also known as quality of the evidence or confidence in the estimates) arising from consideration of the often complex pathways that involve multiple tests and management options. Each link in the evidence can - and often does - lower the overall certainty of the evidence required to formulate recommendations and make decisions about tests. The frequency with which an outcome occurs and its importance will influence whether or not a particular step in the linked evidence is critical to decision-making.

CONCLUSIONS

Overall certainty may be expressed by the weakest critical step in the linked evidence. The linked approach to addressing optimal testing will often require the use of decision analytic approaches. We present an example that involves decision modeling in a GRADE Evidence to Decision framework for cervical cancer screening. However, since resources and time of guideline developers may be limited, we describe alternative, pragmatic strategies for developing recommendations addressing test use.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)
04 Faculty of Medicine > Pre-clinic Human Medicine > Department of Clinical Research (DCR)
04 Faculty of Medicine > Medical Education > Institute of General Practice and Primary Care (BIHAM)

UniBE Contributor:

Rutjes, Anne

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

0895-4356

Publisher:

Elsevier

Language:

English

Submitter:

Andrea Flükiger-Flückiger

Date Deposited:

05 Mar 2019 17:45

Last Modified:

20 Feb 2024 14:16

Publisher DOI:

10.1016/j.jclinepi.2019.02.003

PubMed ID:

30738926

BORIS DOI:

10.7892/boris.126630

URI:

https://boris.unibe.ch/id/eprint/126630

Actions (login required)

Edit item Edit item
Provide Feedback